Compound information
- Natural Products
- ZC1759002
- Molecular Formula
- C20H25N3O
- Molecular Weight
- 323.19976242 g/mol
- Structure
-
- IUPAC Name
- 4-benzhydryl-N,N-dimethyl-piperazine-1-carboxamide
- InChI
- InChI=1S/C20H25N3O/c1-21(2)20(24)23-15-13-22(14-16-23)19(17-9-5-3-6-10-17)18-11-7-4-8-12-18/h3-12,19H,13-16H2,1-2H3
- InChI Key
- LRJUEUFQSNXXIG-UHFFFAOYSA-N
- SMILES
- CN(C)C(=O)N1CCN(C(c2ccccc2)c2ccccc2)CC1
- Source
- ZINC000019862693
Warheads
- Urea carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 24 | Ring Count | 3 |
Heteroatom Count | 4 | Rotatable Bond Count | 3 |
Hydrogen Bond Acceptor Count | 2 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 26.79 Å2 | LogP | 2.873 |
LogS | -2.591 | LogD | 3.092 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.007 | Pgp substrate | 0.919 |
HIA | 0.955 | F20 % | 0.215 |
F30 % | 0.165 | Caco-2 | -4.633 |
MDCK | -4.667 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.881 | PPB | 89.484 |
VD | 2.094 | Fu | 0.971 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.001 | CYP1A2 substrate | 0.798 |
CYP2A6 substrate | 0.936 | CYP2B6 substrate | 0.856 |
CYP2C19 inhibitor | 0.372 | CYP2C19 substrate | 0.879 |
CYP2C8 substrate | 0.82 | CYP2C9 inhibitor | 0.205 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.304 |
CYP2D6 substrate | 1.0 | CYP2E1 substrate | 0.888 |
CYP3A4 inhibitor | 0.22 | CYP3A4 substrate | 1.0 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.136 | CL | 5.561 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.53 | Hepatotoxicity | 0.147 |
Mutagenicity | 0.0 | Rat Oral Acute Toxicity | 0.453 |
FDAMDD | 0.397 | Skin Sensitization | 0.98 |
Carcinogenicity | 0.049 | Eye Corrosion | 0.0 |
Eye Irritation | 0.071 | Respiratory Toxicity | 0.414 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.551 | IGC50 | 3.154 |
LC50FM | 1.95 | LC50DM | 0.718 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.462 | NR-AR-LBD | 0.164 |
NR-AhR | 0.026 | NR-Aromatase | 0.028 |
NR-ER | 0.284 | NR-ER-LBD | 0.311 |
NR-PPAR-gamma | 0.134 | SR-ARE | 0.404 |
SR-ATAD5 | 0.31 | SR-HSE | 0.173 |
SR-MMP | 0.014 | SR-p53 | 0.057 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.